Xiaoke Wang1,2, Timothy J Colgan1, Louis A Hinshaw1,2, Nathan T Roberts1,3, Leah C Henze Bancroft1, Gavin Hamilton4, Diego Hernando1,5, Scott B Reeder1,2,5,6,7. 1. Department of Radiology, University of Wisconsin, Madison, Wisconsin. 2. Department of Biomedical Engineering, University of Wisconsin, Madison, Wisconsin. 3. Department of Electrical and Computer Engineering, University of Wisconsin, Madison, Wisconsin. 4. Liver Imaging Group, Department of Radiology, University of California San Diego, La Jolla, California. 5. Department of Medical Physics, University of Wisconsin, Madison, Wisconsin. 6. Department of Medicine, University of Wisconsin, Madison, Wisconsin. 7. Department of Emergency Medicine, University of Wisconsin, Madison, Wisconsin.
Abstract
PURPOSE: To develop and validate a T1 -corrected chemical-shift encoded MRI (CSE-MRI) method to improve noise performance and reduce bias for quantification of tissue proton density fat-fraction (PDFF). METHODS: A variable flip angle (VFA)-CSE-MRI method using joint-fit reconstruction was developed and implemented. In computer simulations and phantom experiments, sources of bias measured using VFA-CSE-MRI were investigated. The effect of tissue T1 on bias using low flip angle (LFA)-CSE-MRI was also evaluated. The noise performance of VFA-CSE-MRI was compared to LFA-CSE-MRI for liver fat quantification. Finally, a prospective pilot study in patients undergoing gadoxetic acid-enhanced MRI of the liver to evaluate the ability of the proposed method to quantify liver PDFF before and after contrast. RESULTS: VFA-CSE-MRI was accurate and insensitive to transmit B1 inhomogeneities in phantom experiments and computer simulations. With high flip angles, phase errors because of RF spoiling required modification of the CSE signal model. For relaxation parameters commonly observed in liver, the joint-fit reconstruction improved the noise performance marginally, compared to LFA-CSE-MRI, but eliminated T1 -related bias. A total of 25 patients were successfully recruited and analyzed for the pilot study. Strong correlation and good agreement between PDFF measured with VFA-CSE-MRI and LFA-CSE-MRI (pre-contrast) was observed before (R2 = 0.97; slope = 0.88, 0.81-0.94 95% confidence interval [CI]; intercept = 1.34, -0.77-1.92 95% CI) and after (R2 = 0.93; slope = 0.88, 0.78-0.98 95% CI; intercept = 1.90, 1.01-2.79 95% CI) contrast. CONCLUSION: Joint-fit VFA-CSE-MRI is feasible for T1 -corrected PDFF quantification in liver, is insensitive to B1 inhomogeneities, and can eliminate T1 bias, but with only marginal SNR advantage for T1 values observed in the liver.
PURPOSE: To develop and validate a T1 -corrected chemical-shift encoded MRI (CSE-MRI) method to improve noise performance and reduce bias for quantification of tissue proton density fat-fraction (PDFF). METHODS: A variable flip angle (VFA)-CSE-MRI method using joint-fit reconstruction was developed and implemented. In computer simulations and phantom experiments, sources of bias measured using VFA-CSE-MRI were investigated. The effect of tissue T1 on bias using low flip angle (LFA)-CSE-MRI was also evaluated. The noise performance of VFA-CSE-MRI was compared to LFA-CSE-MRI for liver fat quantification. Finally, a prospective pilot study in patients undergoing gadoxetic acid-enhanced MRI of the liver to evaluate the ability of the proposed method to quantify liver PDFF before and after contrast. RESULTS:VFA-CSE-MRI was accurate and insensitive to transmit B1 inhomogeneities in phantom experiments and computer simulations. With high flip angles, phase errors because of RF spoiling required modification of the CSE signal model. For relaxation parameters commonly observed in liver, the joint-fit reconstruction improved the noise performance marginally, compared to LFA-CSE-MRI, but eliminated T1 -related bias. A total of 25 patients were successfully recruited and analyzed for the pilot study. Strong correlation and good agreement between PDFF measured with VFA-CSE-MRI and LFA-CSE-MRI (pre-contrast) was observed before (R2 = 0.97; slope = 0.88, 0.81-0.94 95% confidence interval [CI]; intercept = 1.34, -0.77-1.92 95% CI) and after (R2 = 0.93; slope = 0.88, 0.78-0.98 95% CI; intercept = 1.90, 1.01-2.79 95% CI) contrast. CONCLUSION: Joint-fit VFA-CSE-MRI is feasible for T1 -corrected PDFF quantification in liver, is insensitive to B1 inhomogeneities, and can eliminate T1 bias, but with only marginal SNR advantage for T1 values observed in the liver.
Authors: B Henninger; C Kremser; S Rauch; R Eder; H Zoller; A Finkenstedt; H J Michaely; M Schocke Journal: Eur Radiol Date: 2012-05-30 Impact factor: 5.315
Authors: Takeshi Yokoo; Suraj D Serai; Ali Pirasteh; Mustafa R Bashir; Gavin Hamilton; Diego Hernando; Houchun H Hu; Holger Hetterich; Jens-Peter Kühn; Guido M Kukuk; Rohit Loomba; Michael S Middleton; Nancy A Obuchowski; Ji Soo Song; An Tang; Xinhuai Wu; Scott B Reeder; Claude B Sirlin Journal: Radiology Date: 2017-09-11 Impact factor: 11.105
Authors: Houchun Harry Hu; Peter Börnert; Diego Hernando; Peter Kellman; Jingfei Ma; Scott Reeder; Claude Sirlin Journal: Magn Reson Med Date: 2012-06-12 Impact factor: 4.668
Authors: Ildiko Lingvay; Victoria Esser; Jaime L Legendre; Angela L Price; Kristen M Wertz; Beverley Adams-Huet; Song Zhang; Roger H Unger; Lidia S Szczepaniak Journal: J Clin Endocrinol Metab Date: 2009-09-22 Impact factor: 5.958
Authors: D Franz; D Weidlich; F Freitag; C Holzapfel; T Drabsch; T Baum; H Eggers; A Witte; E J Rummeny; H Hauner; D C Karampinos Journal: Int J Obes (Lond) Date: 2017-08-14 Impact factor: 5.095